Aug 01, 2019 8:30am EDT Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th
Jul 18, 2019 2:07pm EDT Veru Announces Dismissal of Lawsuit; Prevails on All Counts in Motion for Summary Judgment
Jun 26, 2019 8:30am EDT Veru Announces Successful Completion of Pre-NDA Meeting with FDA for TADFIN (Tadalafil 5mg and Finasteride 5mg) Combination for the Treatment of Benign Prostatic Hyperplasia
Jun 04, 2019 8:00am EDT Veru Adds Breakthrough Novel Androgen Deprivation Therapy Formulation to its Advancing Prostate Cancer Drug Pipeline Following Successful Meeting with FDA
May 28, 2019 8:30am EDT Veru to Present at the Jefferies 2019 Global Healthcare Conference on June 4th
May 08, 2019 8:30am EDT Veru to Report Fiscal 2019 Second-Quarter Financial Results; Host Conference Call on May 15th
Feb 12, 2019 8:00am EST Veru Announces Scientific Presentations for Novel Prostate Cancer Drug Candidates at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium
